Coinfection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Bordetella Bronchiseptica Pneumonia in a Renal Transplant Patient
Overview
Authors
Affiliations
species cause respiratory infections in both humans and animals. () infection is an uncommon pathogen in humans. The clinical spectrum of infections with SARS-CoV-2 includes viral pneumonia of variable severity, with some patients developing acute respiratory distress syndrome (ARDS), requiring mechanical ventilation support. Transplant patients with coronavirus disease (COVID-19) infection have high mortality. Bacterial coinfection, including pneumonia, have been described in patients with COVID-19. We present a renal transplant patient with COVID-19 pneumonia who developed superinfection and had a rapid clinical and radiological response to azithromycin treatment.
and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.
Miguelena Chamorro B, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S Clin Microbiol Rev. 2023; 36(3):e0016422.
PMID: 37306571 PMC: 10512794. DOI: 10.1128/cmr.00164-22.
Pierce M, Slipke W, Biagi M Antibiotics (Basel). 2022; 11(9).
PMID: 36139980 PMC: 9495116. DOI: 10.3390/antibiotics11091200.
A Case of Bordetella bronchiseptica Bacteremia in a Patient With COVID-19: Brief Report.
Papantoniou S, Tsakiris A, Ladopoulos T, Kranidiotis G, Tamvakos C Cureus. 2021; 13(6):e15976.
PMID: 34336468 PMC: 8318613. DOI: 10.7759/cureus.15976.